Grant ID RP210209
Awarded On August 18, 2021
Title North Texas Clinical Pharmacology Cancer Core
Program Academic Research
Award Mechanism Core Facility Support Awards
Institution/Organization Texas Tech University Health Sciences Center
Principal Investigator/Program Director Li Li
Cancer Sites All Sites
Contracted Amount $2,965,226
Lay Summary

There is an urgent and continued need for translating basic cancer research (discovery) results into improved care for cancer patients, and better interventional tools to cure and/or prevent cancer. An ultramodern core resource has been established, the North Texas Clinical Pharmacology Cancer Core, to help basic cancer researchers and physicians better test and understand new drugs or therapies. Such testing assists investigators to better understand how cancer drugs move in the body, how the drugs treat cancer, how to best deliver these drugs, and how to avoid unwanted side effects. In general, the research team of this Core will support translational cancer researchers to conduct research...

Read More